Cerebrospinal fluid analysis in human immunodeficiency virus infection

Area of Science:

• Neuroscience
• Immunology
• Infectious Diseases

Background:

• Human immunodeficiency virus (HIV) infection can affect the central nervous system.
• Assessing neurological involvement in HIV+ individuals often involves cerebrospinal fluid (CSF) analysis.
• Interpreting CSF findings in HIV+ patients requires understanding potential confounding factors.

Purpose of the Study:

• To evaluate cerebrospinal fluid (CSF) analytes in human immunodeficiency virus (HIV+) individuals.
• To assess the relationship between CSF abnormalities and neurological involvement or disease staging.
• To identify potential misinterpretations of CSF results in HIV+ patients.

Main Methods:

• Analysis of CSF samples from 59 HIV+ individuals.
• Measurement of glucose, total protein, cell counts, p24 antigen, CSF:serum albumin/IgG ratios, and oligoclonal bands.
• Correlation of CSF analyte abnormalities with CD4+ lymphocyte counts and HIV disease staging.

Main Results:

• Eighty percent of CSF samples exhibited one or more abnormalities.
• CSF oligoclonal banding (31%) and disturbed CSF:serum albumin/IgG ratios (30%) correlated with decreased CD4+ counts.
• Disturbances in CSF:serum albumin/IgG ratios also related to non-neurological HIV disease severity.
• No significant relationship found between CSF abnormalities and the presence of diagnosed neurological disease.

Conclusions:

• CSF abnormalities are common in HIV+ individuals and can mimic opportunistic infections.
• Oligoclonal bands and altered CSF:serum albumin/IgG ratios are linked to immune status (CD4+ count) and disease stage.
• CSF findings may lead to artifactually elevated enzyme levels, potentially causing erroneous clinical decisions.
• The presence of neurological disease in HIV+ patients was not significantly correlated with the observed CSF abnormalities, highlighting the need for cautious interpretation.